Detalhe da pesquisa
1.
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban.
Thromb J
; 22(1): 24, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429728
2.
Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease.
Int J Mol Sci
; 23(19)2022 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233355
3.
Hemodynamic and Hemostatic Response to Blood Flow Restriction Resistance Exercise in Coronary Artery Disease: A Pilot Randomized Controlled Trial.
J Cardiovasc Nurs
; 36(5): 507-516, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496365
4.
Idarucizumab for dabigatran reversal in daily clinical practice: A case series.
Eur J Anaesthesiol
; 37(10): 874-878, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32175987
5.
Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation.
Eur J Clin Pharmacol
; 75(8): 1069-1075, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31139866
6.
Diabetes and smoking are more important for prognosis of patients with peripheral arterial disease than some genetic polymorphisms.
Vasa
; 48(3): 229-235, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526437
7.
Heparin-induced thrombocytopenia in an obese pregnant woman with venous thrombosis.
J Obstet Gynaecol
; 42(7): 3380-3381, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913434
8.
Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients.
Sci Rep
; 14(1): 6831, 2024 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514764
9.
Acute effects of high intensity interval training versus moderate intensity continuous training on haemostasis in patients with coronary artery disease.
Sci Rep
; 14(1): 1963, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263210
10.
Insulin resistance, lipids and body composition in patients with coronary artery disease after combined aerobic training and resistance training: a randomised, controlled trial.
Diabetol Metab Syndr
; 15(1): 47, 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918949
11.
Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment.
J Clin Med
; 12(19)2023 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37834987
12.
Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis.
Sci Rep
; 13(1): 16734, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794095
13.
Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis.
Dis Markers
; 2022: 2993309, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082237
14.
The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction.
Dis Markers
; 2022: 6206802, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36312588
15.
Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving Rivaroxaban.
J Cardiovasc Dev Dis
; 9(7)2022 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877567
16.
HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction.
Dis Markers
; 2022: 9539676, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36330203
17.
Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis-A Randomized Trial.
J Clin Med
; 10(13)2021 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34279471
18.
The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation.
Sci Rep
; 11(1): 5920, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723299
19.
Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation.
Sci Rep
; 11(1): 13908, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230559
20.
Hyperhomocysteinemia and thrombophilia.
Clin Chem Lab Med
; 48 Suppl 1: S89-95, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21105837